Record Details

<p style="text-align: justify;">Effectiveness of unani regimen in protecting high risk population from COVID -19: A pilot study</p>

Online Publishing @ NISCAIR

View Archive Info
 
 
Field Value
 
Authentication Code dc
 
Title Statement <p style="text-align: justify;">Effectiveness of unani regimen in protecting high risk population from COVID -19: A pilot study</p>
 
Added Entry - Uncontrolled Name Khan, Asim Ali; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Parveen, Naheed ; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Raza, Rahat ; Regional Research Institute of Unani Medicine, Abul Fazal Enclave, Jamia Nagar, New Delhi 110025, India
Akhtar, Jamal ; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Anjum, Nighat ; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Kumar, Pradeep ; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi. 110058
Kumar, Pawan ; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Javed, Ghazala ; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Meena, Ram Pratap; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Urooj, Shaista ; Regional Research Institute of Unani Medicine, Abul Fazal Enclave, Jamia Nagar, New Delhi 110025, India
Thapa, Harendra ; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Alam, Shah ; Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, 61-65, Institutional Area, Opp. D block Janakpuri, New Delhi 110058, India
Ministry of AYUSH, Government of India
 
Uncontrolled Index Term Clinical research; Unani medicine
COVID -19; Immune status; Khameera Marwareed; Tiryaq Arba; Unani Joshanda.
 
Summary, etc. <p style="text-align: justify;">The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally. COVID-19 presents varied clinical features. The present study focuses on number of patients turning COVID-19 positive, change in Immune Status Questionnaire (ISQ) and WHO quality of life- Bref (WHO Qol – BREF) scales after taking intervention. This open labelled, double arm, controlled, interventional, clinical trial was conducted on high-risk individuals i.e., those residing with a COVID-19 positive member in the identified quarantine area. This twin armed study was conducted on asymptomatic individuals exposed to COVID -19. The test group were prescribed Unani poly-herbal decoction together with Unani formulations <em>Khamira Marwareed </em>and<em> </em><em>Tiryaq e Arba</em> whereas the control group was not on any intervention. The duration of intervention was 20 days; follow ups were planned on day 10 and day 20. Of the 81 participants enrolled, none of the patients turned COVID-19 positive. However, 13.58% (n=11) developed COVID like symptoms and 70 patients completed the study. The mean age of the participants was 41.42±16.9 years; however, majority of the participants were 18-28 years male with<em> </em><em>Damvi</em> (Sanguine) temperament. The quality of life of the intervention group improved significantly however, the immune status in both the groups increased with <em>P</em> &lt;0.001. The Unani prophylactic regimen provides a 62% (relative risk reduction) protection against COVID -19. This pilot study paves for a study on a larger population. No adverse effects were observed during the study. Absence of biochemical investigations were limitations to the study.</p>
 
Publication, Distribution, Etc. Indian Journal of Natural Products and Resources (IJNPR) [Formerly Natural Product Radiance (NPR)]
2022-08-13 01:04:42
 
Electronic Location and Access application/pdf
http://op.niscair.res.in/index.php/IJNPR/article/view/58610
 
Data Source Entry Indian Journal of Natural Products and Resources (IJNPR) [Formerly Natural Product Radiance (NPR)]; ##issue.vol## 13, ##issue.no## 2 (2022): June 2022
 
Language Note en
 
Nonspecific Relationship Entry http://op.niscair.res.in/index.php/IJNPR/article/download/58610/465600524
 
Terms Governing Use and Reproduction Note Authors who publish with IJNPR agree that once published copyright of the article will be transferred to the publisher, with the work simultaneously licensed under a Creative Commons Attribution-BY-NC-ND 4.0 International License.. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Except where otherwise noted, the Articles on this site are licensed underCreative Commons License: CC Attribution-Noncommercial-No Derivative Works 2.5 India